SCHEMBL30906574

CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)O

nearest known ligand 0.69

Predicted protein targets (top 12)

	gene	UniProt	supporting neighbours	confidence
▸	NPY2R	P49146	10/20	0.66

▸	NPY1R	P25929	9/20	0.66

▸	NPY4R	P50391	8/20	0.66

▸	NPY5R	Q15761	8/20	0.66

▸	EP300	Q09472	1/20	0.60

▸	HIF1A	Q16665	1/20	0.60

▸	CALCR	P30988	3/20	0.59

▸	RAMP3	O60896	1/20	0.59

▸	NTSR2	O95665	2/20	0.58

▸	NTSR1	P30989	2/20	0.58

▸	SORT1	Q99523	2/20	0.58

▸	TFPI	P10646	1/20	0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30906569	0.94	NPY2R (0.69)	NPY2RNPY1RNPY4RNPY5REP300
SCHEMBL30906483	0.94	NPY2R (0.63)	NPY2RNPY1RNPY4RNPY5REP300
SCHEMBL30726583	0.91	NPY2R (0.62)	NPY2RNPY1RNPY4RNPY5RCALCR
SCHEMBL30906330	0.91	NPY2R (0.64)	NPY2RNPY1RNPY4RNPY5RCALCR
SCHEMBL30906432	0.91	NPY2R (0.64)	NPY2RNPY1RNPY4RNPY5RCALCR
SCHEMBL30906423	0.91	NPY2R (0.64)	NPY2RNPY1RNPY4RNPY5RCALCR
SCHEMBL30906497	0.89	NPY2R (0.69)	NPY2RNPY1RNPY4RNPY5REP300
SCHEMBL31182683	0.89	NPY2R (0.71)	NPY2RNPY1RNPY4RNPY5REP300
SCHEMBL29726735	0.89	EP300 (0.67)	NPY2RNPY1RNPY4RNPY5REP300
SCHEMBL30277961	0.89	NPY2R (0.69)	NPY2RNPY1RNPY4RNPY5REP300

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-4598964-A2	ANTI-IGE ANTIBODIES	Abwiz Bio, Inc. (US)	2025-08-13	—	—	EP	disclosed
US-20240182599-A1	ANTI-IGE ANTIBODIES	ABWIZ BIO, INC.	2024-06-06	—	—	US	disclosed
WO-2024076785-A2	ANTI-IGE ANTIBODIES	ABWIZ BIO, INC. (US)	2024-04-11	—	—	WO	disclosed